NeuroHeal
Cambridge, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $520M
Overview
Develops regenerative small molecule therapies to repair nerve damage and treat neurological injuries and diseases.
NeuroscienceRegenerative Medicine
Technology Platform
A drug discovery platform focused on identifying small molecules that promote nerve regeneration and modulate the neuroinflammatory environment.
Funding History
1Total raised:$520M
Series B$520M
Opportunities
A successful therapy for spinal cord injury would address a massive unmet need and establish a new treatment modality.
Risk Factors
The complexity of CNS repair and history of clinical failures in neurology pose extremely high development risks.
Competitive Landscape
Faces competition from cell therapy and biologic approaches in neurology, but its small molecule strategy offers potential advantages in delivery and cost.